Articles tagged with Pharmacology
A national clinical trial found that oxybutynin significantly reduced hot flash frequency and quality of life for men undergoing hormone therapy for prostate cancer. The study showed substantial improvements in hot flash symptoms, often within the first week of treatment.
Researchers found that carrying one mutant copy of ATP13A2 and GBA1 drives a slow, progressive neurodegeneration in flies, leading to movement problems, neuron loss, and disruption in neural communication. Accumulation of glucosylceramide in glial cells is linked to the disease process.
The UH College of Pharmacy is expanding its graduate program to offer a Doctor of Philosophy and Master of Science in Population Health & Pharmacoepidemiology, addressing a growing demand for training in evaluating medication safety and effectiveness.
The UK's response to NPS deaths highlights the importance of international cooperation and domestic legislation in reducing harm. Effective controls implemented in producing countries, such as China, were associated with larger reductions in NPS detections than controls introduced solely within consuming countries.
A pharmacokinetic recall study involving 114 Estonian Biobank participants reveals functional impact of rare CYP2C19 and CYP2D6 variants. These variants significantly affect how drugs are processed in the human body, emphasizing the need to look beyond common pharmacogenetic markers.
A BSC study analyzed 8,906 patient samples to explore disease connections between women and men. It identified different biological pathways for co-occurring diseases depending on sex, highlighting the need for sex-specific risk-reduction strategies.
Researchers used the African turquoise killifish as a rapid-aging model to study kidney decline. The study revealed that sodium-glucose co-transporter 2 inhibition improves age-dependent kidney microvascular rarefaction, protecting against aging-related damage.
Researchers decode the molecular mechanisms of toad venom's medicinal properties, revealing a link to serotonin receptor interactions. The study identifies key components and their selective agonist activities on depression-related receptors, shedding light on traditional Chinese medicine's modern interpretation.
Computational analysis reveals two strategies: stealthy plasmids pick up new genes first, while manipulative plasmids help them spread rapidly. This 'stealth-first' process can aid in predicting future resistance threats and tracking their emergence.
A multidisciplinary team at USC has developed selective compounds that inhibit an enzyme tied to brain inflammation in people at genetic risk for Alzheimer’s. The inhibitors preserve normal brain function and cross the blood-brain barrier, suggesting a promising therapeutic approach for neurodegenerative diseases.
Researchers at the University of Missouri are developing AI models to accurately detect melanoma by analyzing images of skin abnormalities. The technology can help dermatologists identify cases that may require closer attention, leading to earlier treatment and improved health outcomes.
Scientists develop ultra-selective crystalline membranes to recycle polluted textile wastewater and improve pharmaceutical medicine purity. The technology could significantly reduce energy consumption, enabling large-scale water reuse in industries.
Researchers at the University of Oulu have developed a pine-bark-based water-treatment medium that efficiently removes antibiotics and other pharmaceuticals from wastewater treatment plant effluent. The method uses modified pine bark and combination materials, achieving removal efficiencies in the tens of percent to over 90%.
A national clinical trial found that abemaciclib, an oral cancer drug, may slow tumor growth in patients with aggressive meningiomas with specific genetic mutations. The trial showed promising results, with a median progression-free survival of 10 months and a median overall survival of 29 months.
Researchers deciphered the function of ion channel TMEM175, showing it conducts potassium ions and protons in lysosomal membranes. This discovery establishes its decisive role in maintaining optimal pH levels, facilitating degradation processes, and may lead to new treatments for Parkinson's disease.
Researchers at the University of Virginia Health System have discovered how the keto diet protects against epilepsy seizures by regulating brain cell activity. The team found that a specific cellular receptor, HCAR2, plays a crucial role in reducing seizures, and may be targeted for new treatments.
Research reveals that high blood pressure significantly increases risk of heart damage caused by anthracycline cancer treatments. The study identifies a 'perfect storm' effect when high blood pressure and anthracyclines coincide, leading to heart failure.
A major U.S. clinical trial has uncovered a genetic factor that may inform how to optimize the dosing of abiraterone, a widely used hormone treatment for advanced prostate cancer. Researchers found that men who carry a specific version of the gene SULT2A1 clear abiraterone from their bodies more slowly, which could affect how well it w...
Salk Institute scientists found distinct disease courses and tolerance mechanisms in younger and older mice with sepsis, indicating a need for age-tailored therapies. The study suggests that future treatments may focus on controlling infection-generated damage rather than just targeting the pathogen.
A new clinical trial, PAGODA, seeks to minimize treatment interruptions and help patients complete their chemotherapy as planned. The trial will test a structured plan to guide doctors in making small, proactive changes to chemotherapy doses to prevent treatment delays.
Researchers uncover a key ion channel, TRPM4, that regulates intestinal fluid balance and identify a new druggable site. This discovery provides a blueprint for designing targeted treatments for gastrointestinal disorders.
Four Mainz University researchers have been awarded prestigious ERC Consolidator Grants to develop new treatments and understand complex biological processes. The grants will support research projects focused on signal specificity, racialization, and socialist Red Cross societies.
A Mizzou researcher developed an antibody that attaches to and lights up EphA2 protein in cancerous tumors, allowing for non-invasive detection and identification of patients who can benefit from targeted treatments. This innovation could save time and money while advancing precision medicine.
Researchers found that pitavastatin directly inhibits the anti-apoptotic protein Mcl-1, a key driver of survival and resistance in TNBC cells. The study showed pitavastatin effectively eliminates cancer stem-like cell populations and reduces tumor growth, angiogenesis, and lung metastasis.
A new nanodrug called Nano-273 could offer improved survival for patients with pancreatic and lung cancers by activating the immune system and blocking tumor growth. The drug, developed by University of Houston researcher Wei Gao, has shown promising results in early studies.
Researchers found that male fish exposed to vitamin C and potassium perchlorate showed improved fertility and less damage to their testes compared to those exposed only to the chemical. The study suggests a potential safeguard for individuals regularly exposed to these chemicals, including military personnel.
A new clinical trial, RECIPROCAL, seeks to optimize targeted radiation therapy for men with advanced prostate cancer by adjusting treatment based on individual PSA levels. The trial aims to minimize side effects while preserving survival benefits.
Researchers create a novel mathematical framework to control biological noise, enabling precise single-cell control. The 'Noise Robust Perfect Adaptation' technology suppresses stochastic fluctuations while maintaining stable average behavior, with promising applications in cancer therapy and synthetic biology.
Researchers at Kanazawa University have developed a new combination therapy that combines CAR-T cell therapy with a SUMOylation inhibitor, which effectively suppresses MYC activity and slows the growth of Burkitt's lymphoma cells. The approach extends survival rates in mouse models by up to 80%.
Current Molecular Pharmacology has achieved a major milestone with its real-time CiteScore advancing to 7.2, indicating the journal's high-quality research and rigorous peer-review process. The journal continues to strengthen its position as a key platform for innovative pharmacological research.
A study published in EMBO Molecular Medicine has identified a combination of statins and phenothiazines that shows promise in treating aggressive neuroblastoma. The drug combination was found to impede tumour growth and improve survival rates in laboratory trials with mice.
The journal has achieved a real-time CiteScore of 2.4, doubling its Impact Factor from the previous year to 1.5. This advancement highlights CPA's commitment to quality and its expanding role in disseminating high-quality research across pharmaceutical sciences.
Researchers develop experimental drugs that encourage mitochondria in cells to work harder and burn more calories. The findings offer a framework for designing safe and effective weight-loss treatments with potential benefits for metabolic health and neurodegenerative diseases.
A new study from Texas A&M University reveals that circadian disruptions change the structure of mammary glands, weaken immune defenses, and fuel aggressive breast cancer. Disabling an immune checkpoint molecule called LILRB4 helps restore the immune system's ability to fight back.
Researchers at University Hospitals and Case Western Reserve University have discovered a novel enzyme, SCoR2, that removes nitric oxide from proteins controlling fat build-up. Inhibition of this enzyme prevents weight gain and liver injury in mouse models, also lowering bad cholesterol.
In a new study, Northwestern scientists identified a previously unknown toxic sub-species of amyloid beta oligomers that drive brain changes in Alzheimer's disease. NU-9 decreased this toxin and reduced damage in a mouse model, suggesting it could prevent or delay the cascade of toxic events that destroy neurons.
The study reveals that despite differences in ARG abundance between the Qinghai-Xizang Plateau and polar regions, their types are similar, with bacitracin and multidrug-resistant ARGs being common. Most ARGs belong to the low-risk category, but high-risk variants were detected, indicating a need for continuous monitoring.
Researchers at UVA Health System discover how traumatic brain injury increases Alzheimer's risk and find a potential prevention strategy using a hollowed-out virus to deliver repair supplies. The approach could help limit neurodegeneration and potentially prevent other neurological diseases.
Acute sepsis alters fluid kinetics and creates a 'third space' resistant to adrenergic modulation, leading to maldistribution of crystalloid fluid. Vasoactive drugs have limited effect on fluid distribution in septic sheep compared to healthy animals.
A blood test may help doctors identify which patients with colon cancer can benefit from anti-inflammatory medication and chemotherapy after surgery. The test measures circulating tumor DNA levels, and high-risk patients who test positive see improved survival rates when taking celecoxib with chemotherapy.
Researchers have created a three-dimensional human heart organoid that can replicate atrial fibrillation, a condition affecting millions worldwide. The organoids' ability to study heart development, diseases, and drug responses has the potential to revolutionize arrhythmia treatment.
Transformers and graph neural networks integrated with multiple pre-training tasks improve drug discovery accuracy. Molecule captions facilitate collaboration between large language models and drug discovery.
A UBC Okanagan study found that microdosing psychedelics temporarily improves mood, creativity, and wellbeing, but these effects do not persist on non-dosing days. The study, tracking over 1,435 participants from 49 countries, suggests that microdosing may 'reactivate' or build upon prior effects of larger-dose psychedelic experiences.
The study assessed deramciclane's antidepressant potential in two preclinical tests with predictive validity. Deramciclane demonstrated significant anxiolytic and antidepressant-like activity in the forced swim test, but showed no effect in the bilateral olfactory bulbectomized rat model.
A new online tool has been developed to detect drug exposure directly from patient samples, revealing a more accurate picture of what drugs are in a person's body than what is listed on their medical record. The tool uses a publicly-available library of chemical fingerprints from thousands of drugs and their breakdown products.
Researchers at Martin Luther University Halle-Wittenberg have developed a promising new substance that inhibits the ability of tuberculosis bacteria to produce energy and causes them to die. The compound, PRP020, targets the pathogen's ATP synthase but attacks a different site than existing drugs like bedaquiline.
NEJM Clinician curates highly relevant clinical insights from over 150 peer-reviewed journals to give physicians clear guidance without the noise. The weekly publication delivers summaries and commentary in a concise, 30-minute read, helping healthcare providers stay informed and confident in their decisions.
Researchers found that plant phenolic acids can dramatically boost the activity of existing antibiotics against multidrug resistant E. coli, reducing the chance of new resistance emerging. The compounds also make it easier for antibiotics to enter and stay inside bacterial cells.
Scientists at the University of Bonn have discovered a mechanism to inhibit the P2X4 receptor, which plays a role in chronic pain, inflammation, and some types of cancer. The findings open up a new pathway for developing effective drugs.
Researchers have developed a new microscopy technique that reveals influenza viruses actively recruit clathrin proteins to facilitate their entry into living cells. The study provides key insights into the development of antiviral drugs and the behavior of other viruses.
MIT chemists successfully synthesized verticillin A, a fungal compound that has shown potential as an anticancer agent. The researchers then generated derivatives of the compound and tested them against pediatric brain tumors, finding that some were effective against cancer cells with high levels of EZHIP protein.
The UK has published a new clinical guideline recommending pharmacogenetic testing for all patients prescribed clopidogrel to determine their individual genetic response to the medication. This is due to variations in the CYP2C19 enzyme, which affects how clopidogrel works in different people.
Researchers at LMU uncovered two crucial proteins controlling the assembly of Toxoplasma gondii's invasion machinery. The discovery provides a promising avenue for developing targeted therapies against toxoplasmosis.
Scientists predict that a simple AI-assisted blood test could diagnose cancer earlier and with greater precision by analyzing tiny particles known as exosomes. Exosomes carry molecular signatures of cancerous cells, offering a real-time view of what's happening inside tumors.
Researchers analyzed 1,240 wastewater samples from 351 cities worldwide and discovered latent antimicrobial resistance genes. The study highlights the need for broader surveillance of resistance in wastewater to curb future pandemics.
A monthly injection has helped 90% of severe asthma patients reduce their reliance on daily steroid tablets. Treatment with tezepelumab improved asthma symptoms, lung function, and overall quality of life, with two-thirds of patients experiencing no asthma attacks.
Researchers have identified a key mechanism behind statin-induced muscle damage, paving the way for new statins with reduced side effects. By understanding how statins interact with muscle proteins, scientists can design safer alternatives that preserve cholesterol-lowering benefits.
Researchers at the University of Virginia Health System have developed a new treatment for acute myeloid leukemia, a deadly form of blood cancer. The FDA-approved medication works by disrupting cellular protein interactions that drive leukemia cell growth and survival, offering patients a potential cure.
The Virtual Cell Pharmacology Initiative (VCPI) aims to build the first standardized framework for virtual cell modeling in drug discovery. Ginkgo Datapoints is offering free high-throughput RNA profiling via its platform, generating over 12 billion data points and aiming to test at least 100,000 compounds.
A systematic review and meta-analysis found that lithium supplementation did not significantly improve cognitive function in individuals with mild cognitive impairment or Alzheimer's disease. Alternative formulations like LIT-O may be a potential alternative to harness lithium's neuroprotective properties more efficiently.